Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
RESEARCH TOOLSreports
Cognition Therapeutics (CGTX) Stock Price & Analysis
77 Followers
CGTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.90 - $2.95
Previous Close$1.91
Volume124.31K
Average Volume (3M)147.79K
Market Cap
$76.51M
Enterprise Value$42.51M
Total Cash (Recent Filing)$34.67M
Total Debt (Recent Filing)$668.00K
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Aug 06, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.92
Shares Outstanding40,058,498
10 Day Avg. Volume134,336
30 Day Avg. Volume147,793
Standard Deviation0.27
R-Squared0.09
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)3.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.03
Forecast
1Y Price Target
$11.00Price Target Upside475.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Cognition Therapeutics News
Ownership Overview
48.00% Insiders
2.91% Mutual Funds
15.94% Other Institutional Investors
33.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CGTX FAQ
What was Cognition Therapeutics’s price range in the past 12 months?
Cognition Therapeutics lowest stock price was $0.90 and its highest was $2.95 in the past 12 months.
What is Cognition Therapeutics’s market cap?
Currently, no data Available
When is Cognition Therapeutics’s upcoming earnings report date?
Cognition Therapeutics’s upcoming earnings report date is Aug 06, 2024 which is in 30 days.
How were Cognition Therapeutics’s earnings last quarter?
Cognition Therapeutics released its earnings results on May 07, 2024. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.247 by -$0.023.
Is Cognition Therapeutics overvalued?
According to Wall Street analysts Cognition Therapeutics’s price is currently Undervalued.
Does Cognition Therapeutics pay dividends?
Cognition Therapeutics does not currently pay dividends.
What is Cognition Therapeutics’s EPS estimate?
Cognition Therapeutics’s EPS estimate is -$0.23.
How many shares outstanding does Cognition Therapeutics have?
Cognition Therapeutics has 40,058,500 shares outstanding.
What happened to Cognition Therapeutics’s price movement after its last earnings report?
Cognition Therapeutics reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.247. Following the earnings report the stock price went down -3.518%.
Which hedge fund is a major shareholder of Cognition Therapeutics?
Among the largest hedge funds holding Cognition Therapeutics’s share is Carlson Capital LP. It holds Cognition Therapeutics’s shares valued at 389K.
---
Cognition Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.00 (475.92% Upside)
$11.00 (475.92% Upside)
Hedge Fund Trend
Decreased
By 24.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.8%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.90%
12-Months-Change
Fundamentals
Return on Equity
-89.00%
Trailing 12-Months
Asset Growth
-14.92%
Trailing 12-Months
Company Description
Cognition Therapeutics
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
---
CGTX Earnings Call
Q4 2024
0:00 / 0:00
---
CGTX Stock 12 Month Forecast
Average Price Target
$11.00
▲(475.92% Upside)
Technical Analysis
Best Analysts Covering CGTX
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
-11.65%
reiterated a buy rating 2 months ago
Copying Jay Olson's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -11.65% per trade.
---